Ezra, the NY-based startup transforming early cancer screening using MRI, announced today that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting r
October 20, 2020
· 3 min read